Crinetics Pharmaceuticals, Inc. (CRNX) · Sep 1, 2026 · Acquisition
$10B acquisition — Merger closed at the previously disclosed $85.00 cash-per-share consideration
Vertex has completed its $10 billion acquisition of Crinetics at $85 per share. The deal was already disclosed, so this is confirmation, not a surprise.
This is a closing confirmation, not a fresh deal surprise. Vertex completed the merger on September 1, 2026, after the transaction and its $85.00-per-share cash terms had already been disclosed on July 6. The filing says the merger became effective on the Closing Date (Introductory Note). 〔0〕
Shareholders receive cash, while the equity story ends. Each eligible Crinetics share was converted into the right to receive $85.00 in cash, and holders ceased to have stockholder rights other than the right to receive that consideration (Introductory Note; Material Modification to Rights of Security Holders).
The transaction fully removes Crinetics from the public market. Vertex now owns Crinetics as a wholly owned subsidiary; Nasdaq trading was suspended, and the company requested delisting and deregistration (Changes in Control; Delisting). 〔1〕
Operational control has transferred to Vertex. Crinetics’ directors resigned, its prior officers were removed, and Charles Wagner, Prasanna Thombre and Omar White became president, treasurer and secretary of the surviving subsidiary (Changes in Officers and Directors). 〔2〕
Net read: in line and fully priced in. The filing confirms the expected completion of the announced all-cash acquisition; it adds execution certainty but does not change the disclosed price, strategic terms, or shareholder outcome.
Form 25 delisting and Form 15 deregistration
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!